Please use this identifier to cite or link to this item: https://doi.org/10.1186/2251-6581-12-46
Title: Frequency and genetic spectrum of maturity-onset diabetes of the young (MODY) in southern New Zealand
Authors: Wheeler, B.J
Patterson, N
Love, D.R
Prosser, D
Tomlinson, P
Taylor, B.J
Manning, P 
Keywords: gliclazide
glucokinase
glucose
hepatocyte nuclear factor 1beta
insulin
insulin aspart
isophane insulin
acanthosis nigricans
adolescent
Article
case report
child
chromosome 17q
chromosome deletion
dehydration
exon
face dysmorphia
female
GCK gene
gene loss
gene mutation
genetic screening
glucose blood level
HNF1B gene
human
hyperglycemia
hypernatremia
insulin dependent diabetes mellitus
insulin resistance
intellectual impairment
male
morning dosage
mucocutaneous candidiasis
New Zealand
non insulin dependent diabetes mellitus
prevalence
school child
Issue Date: 2013
Citation: Wheeler, B.J, Patterson, N, Love, D.R, Prosser, D, Tomlinson, P, Taylor, B.J, Manning, P (2013). Frequency and genetic spectrum of maturity-onset diabetes of the young (MODY) in southern New Zealand. Journal of Diabetes and Metabolic Disorders 12 (1) : 46. ScholarBank@NUS Repository. https://doi.org/10.1186/2251-6581-12-46
Rights: Attribution 4.0 International
Abstract: Maturity-Onset Diabetes of the Young (MODY) is a monogenic form of diabetes, consisting of a heterogeneous group of autosomal dominant inherited disorders. Typical onset is in individuals prior to twenty five years, and presentation can mimic type 1 or 2 diabetes. Molecular genetic testing can allow precise identification of the different MODY sub-types. Making a specific diagnosis of MODY can have important implications for the guidance of appropriate treatment, prognosis and genetic counselling.We present the cases of three children and their families diagnosed with MODY over the past two years. These families highlight the features of three of the more common MODY subtypes, including two with novel mutations, one of which segregates in a kindred that is strongly affected by both MODY and classic autoimmune mediated diabetes. To date, we have identified a prevalence of MODY in the paediatric diabetes population of the lower South Island, New Zealand, of approximately 2.5%. This prevalence, along with increasing access to molecular genetic testing, highlights the importance of consideration of MODY in atypical diabetes presentations in the paediatric/adolescent population. © 2013 Wheeler et al.; licensee BioMed Central Ltd.
Source Title: Journal of Diabetes and Metabolic Disorders
URI: https://scholarbank.nus.edu.sg/handle/10635/183187
ISSN: 22516581
DOI: 10.1186/2251-6581-12-46
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_2251-6581-12-46.pdf96.23 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons